Spero Therapeutics and partner GSK are stopping a late-stage trial of an experimental oral drug for complicated urinary tract ...

A COMMON over-the counter medication that’s been available for decades and is taken by millions worldwide has been singled ...

Popular over-the-counter drugs used to treat uncomfortable urinary tract infections may come with a potential cancer risk.

A common over-the counter medication that’s been available for decades and is taken by millions worldwide has been singled out for its possible cancer risk.

Case studies illustrate how embarrassment can prevent patients from seeking necessary medical help for foreign bodies lodged ...

GSK’s decision to swoop in and save Spero Therapeutics’ antibiotic three years ago appears to have paid off based on a fresh ...

Spero and GSK halt a UTI drug trial due to early success; Sanofi plans vaccine production in Vietnam; Brazil investigates ...

The British drugmaker may have succeeded in reviving an oral antibiotic previously rejected by the FDA when it was under development at Spero.

British pharmaceutical company GSK PLC (GSK) and its Massachusetts-based partner Spero Therapeutics (SPRO) said on Wednesday ...

GSK Plc halted a trial following positive results for an oral antibiotic to treat complicated urinary tract infections that could replace an intravenous medicine that is typically used.

A common over-the-counter medication taken by more than 100 million people worldwide for urinary tract infections has been ...

Shares of Spero Therapeutics gained after the company and GSK ended their trial for a treatment for complicated urinary tract infections early after it met its primary endpoint. The stock more than ...